Optimal Treatment Regimens for 5′‐Deoxy‐5‐fluorouridine, with or without (E)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine, against Various Tumors in Mice

por Iigo, Masaaki, Miwa, Masanori, De Clercq, Erik
Publicado 1990

Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology

por Sakamoto, Kotaro, Kanematsu-Yamaki, Yoko, Kamada, Yusuke, Oka, Masahiro, Ohnishi, Toshiyuki, Miwa, Masanori, Asami, Taiji, Inooka, Hiroshi
Publicado 2017

Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine

por Ninomiya, Yasuyuki, Miwa, Masanori, Eda, Hiroyuki, Sahara, Hiroshi, Fujimoto, Kaori, Ishida, Masako, Umeda, Isao, Yokose, Kazuteru, Ishitsuka, Hideo
Publicado 1990

Identification of the first highly selective inhibitor of human lactate dehydrogenase B

por Shibata, Sachio, Sogabe, Satoshi, Miwa, Masanori, Fujimoto, Takuya, Takakura, Nobuyuki, Naotsuka, Akihiko, Kitamura, Shuji, Kawamoto, Tomohiro, Soga, Tomoyoshi
Publicado 2021

Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson’s Disease

por Takada, Fumito, Kasahara, Takahito, Otake, Kentaro, Maru, Takamitsu, Miwa, Masanori, Muto, Kei, Sasaki, Minoru, Hirozane, Yoshihiko, Yoshikawa, Masato, Yamaguchi, Junichiro
Publicado 2022

Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses

por Anthoney, D Alan, Naik, Jay, MacPherson, Iain RJ, Crawford, Donna, Hartley, John M, Hartley, Janet A, Saito, Tomohisa, Abe, Masaichi, Jones, Keith, Miwa, Masanori, Twelves, Christopher, Evans, TRJ
Publicado 2012